These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30900171)

  • 1. Fragile X Syndrome: Introduction.
    Reches A
    Methods Mol Biol; 2019; 1942():3-10. PubMed ID: 30900171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Triplet expansion cytosine-guanine-guanine: Three cases of OMIM syndrome in the same family].
    González-Pérez J; Izquierdo-Álvarez S; Fuertes-Rodrigo C; Monge-Galindo L; Peña-Segura JL; López-Pisón FJ
    Med Clin (Barc); 2016 Apr; 146(7):311-5. PubMed ID: 26776484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic, carrier and prenatal genetic testing for fragile X syndrome and other FMR-1-related disorders in Johannesburg, South Africa: a 20-year review.
    Essop FB; Krause A
    S Afr Med J; 2013 Oct; 103(12 Suppl 1):994-8. PubMed ID: 24300646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.
    Santa María L; Aliaga S; Faundes V; Morales P; Pugin Á; Curotto B; Soto P; Peña MI; Salas I; Alliende MA
    Genet Res (Camb); 2016 Jun; 98():e11. PubMed ID: 27350105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fragile X syndrome and fragile X-associated tremor ataxia syndrome.
    Hall DA; Berry-Kravis E
    Handb Clin Neurol; 2018; 147():377-391. PubMed ID: 29325626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling unusual X-chromosome patterns during fragile-X syndrome genetic testing.
    Esposito G; Tremolaterra MR; Savarese M; Spiniello M; Patrizio MP; Lombardo B; Pastore L; Salvatore F; Carsana A
    Clin Chim Acta; 2018 Jan; 476():167-172. PubMed ID: 29170104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [FMR1 PREMUTATION CARRIERS - ARE THEY REALLY ASYMPTOMATIC?].
    Elizur S; Berkenstadt M; Ries-Levavi L; Gruber N; Pinhas-Hamiel O; Hassin-Baer S; Raas-Rothschild A; Raanani H; Cukierman-Yaffe T; Orvieto R; Cohen Y; Gabis L
    Harefuah; 2018 Apr; 157(4):241-244. PubMed ID: 29688643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile X syndrome: An overview and update of the FMR1 gene.
    Mila M; Alvarez-Mora MI; Madrigal I; Rodriguez-Revenga L
    Clin Genet; 2018 Feb; 93(2):197-205. PubMed ID: 28617938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tremor/ataxia syndrome related to Fragile X premutation].
    Sallansonnet-Froment M; De Greslan T; Roux X; Bounolleau P; Ouologuem M; Taillia H; Ricard D; Renard JL
    Presse Med; 2010 Feb; 39(2):187-95. PubMed ID: 19419833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal carrier testing for fragile X: counseling issues and challenges.
    Musci TJ; Moyer K
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical guideline of gene FMR1-associated diseases: fragile X syndrome, primary ovarian insufficiency and tremor-ataxia syndrome].
    Milá M; Ramos F; Tejada MI;
    Med Clin (Barc); 2014 Mar; 142(5):219-25. PubMed ID: 23891128
    [No Abstract]   [Full Text] [Related]  

  • 12. The fragile X mental retardation 1 gene (FMR1): historical perspective, phenotypes, mechanism, pathology, and epidemiology.
    Grigsby J
    Clin Neuropsychol; 2016 Aug; 30(6):815-33. PubMed ID: 27356167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Genetic Testing for Fragile X Syndrome by Polymerase Chain Reaction Amplification and Southern Blot Analyses.
    Cai X; Arif M; Wan H; Kornreich R; Edelmann LJ
    Methods Mol Biol; 2019; 1942():11-27. PubMed ID: 30900172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of the
    Wheeler A; Raspa M; Hagerman R; Mailick M; Riley C
    Pediatrics; 2017 Jun; 139(Suppl 3):S172-S182. PubMed ID: 28814538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population.
    Lorefice L; Tranquilli S; Fenu G; Murru MR; Frau J; Rolesu M; Coghe GC; Marrosu F; Marrosu MG; Cocco E
    Neurol Sci; 2015 Dec; 36(12):2213-20. PubMed ID: 26194536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragile X premutation in women: recognizing the health challenges beyond primary ovarian insufficiency.
    Hoyos LR; Thakur M
    J Assist Reprod Genet; 2017 Mar; 34(3):315-323. PubMed ID: 27995424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragile X syndrome.
    Saldarriaga W; Tassone F; González-Teshima LY; Forero-Forero JV; Ayala-Zapata S; Hagerman R
    Colomb Med (Cali); 2014; 45(4):190-8. PubMed ID: 25767309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, molecular, and pharmacological aspects of FMR1 related disorders.
    Pugin A; Faundes V; Santa María L; Curotto B; Aliaga S; Salas I; Soto P; Bravo P; Peña MI; Alliende MA
    Neurologia; 2017 May; 32(4):241-252. PubMed ID: 25529181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn, carrier, and early childhood screening recommendations for fragile X.
    Abrams L; Cronister A; Brown WT; Tassone F; Sherman SL; Finucane B; McConkie-Rosell A; Hagerman R; Kaufmann WE; Picker J; Coffey S; Skinner D; Johnson V; Miller R; Berry-Kravis E
    Pediatrics; 2012 Dec; 130(6):1126-35. PubMed ID: 23129072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular screening of intellectually disabled patients and those with premature ovarian failure for CGG repeat expansion at FMR1 locus: Implication of combined triplet repeat primed polymerase chain reaction and methylation-specific polymerase chain reaction analysis.
    Muthuswamy S; Dean DD; Agarwal S
    Neurol India; 2016; 64(6):1175-1179. PubMed ID: 27841182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.